Balaji Amines Ltd (BALAMINES) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Balaji Amines Ltd on NSE and BSE, with an AI summary of each filing.
Disclosure under Regulation 30 (2) read with Para A(20) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirement Regulations) 2015.
Others (Uncategorized) · 04 Nov 2026, 12:01 am
Balaji Amines Receives Court Summons Over Alleged Drugs and Cosmetics Act Violations Balaji Amines Limited and all its directors have received summons from the City Civil and Sessions Court, Ahmedabad, requiring an appearance on 4th Nov'26 in person or via pleader. The summons, dated 15th Oct'26 and received on 3rd Nov'26, pertains to alleged violations under Sections 16(1)(a), 18(a)(i), 18(c), 34, 27(b)(ii), and 27(d) of the Drugs and Cosmetics Act, 1940. The company confirmed that there is no material impact on its financial position, operations, or other business activities.
Press Release in connection with Un-Audited Financial Results of the Company for the Quarter and Half Year Ended 30th September, 2026
Press Release · 03 Nov 2026, 5:58 pm
Balaji Amines Reports Strong Q2FY27 Earnings Growth Driven by Margin Expansion Balaji Amines reported a consolidated Q2FY27 revenue of ₹472 crore, up 35.6% YoY from ₹348 crore, while total sales volume reached 24,491 MT. Consolidated EBITDA rose 58.2% YoY to ₹106 crore, with EBITDA margins expanding to 22% from 19% in Q2FY26. Net profit surged 81.1% YoY to ₹67 crore, yielding a diluted EPS of ₹20.76. Standalone operations remained zero-debt. Growth was supported by the commissioned 1,440 TPM Acetonitrile expansion and 100,000 TPA DME facility, alongside upcoming EDA derivatives and greenfield projects slated for commissioning in FY27.
Balaji Amines Limited has submitted to the Exchange, Financial Results for the Quarter and Half Year Ended 30th September, 2026
Outcome · 03 Nov 2026, 12:09 am
Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026
Outcome · 03 Nov 2026, 12:01 am
Financial Results for the Quarter and Half Year Ended 30th September, 2026
Financial Result · 02 Nov 2026, 11:55 pm
Balaji Amines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 46,760 (+37.3% YoY | +2.6% QoQ) ■ EBITDA: 10,158 (+69.8% YoY | -12.3% QoQ) ■ EBITDA Margin (%): 21.7 (+416 bps YoY | -369 bps QoQ) ■ PAT: 6,727 (+94.7% YoY | -10.2% QoQ) ■ EPS (INR): 20.8 (+94.6% YoY | -10.2% QoQ) Balaji Amines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Amines & Speciality Chemicals ■ Revenue: 46,420 (+36.1% YoY | +2.5% QoQ) ■ EBIT: 8,926 (+76.6% YoY | -15.4% QoQ) ■ EBIT Margin (%): 19.2 (+441 bps YoY | -405 bps QoQ) Hotel Division ■ Revenue: 717 (-1.1% YoY | -10.3% QoQ) ■ EBIT: 53.2 (-45.5% YoY | -66.7% QoQ) ■ EBIT Margin (%): 7.4 (-605 bps YoY | -1259 bps QoQ)
Intimation of Schedule of Conference Call to discuss Q2FY27 Financial Results.
Intimation · 04 Nov 2026, 4:00 pm
Balaji Amines Schedules Q2FY27 Earnings Conference Call for 4th Nov'26 Balaji Amines Limited will host an earnings conference call on 4th Nov'26 at 04:00 PM IST to discuss its financial results for Q2FY27. Organized by Elara Securities (India) Private Limited, the call will feature Managing Director Mr. D. Ram Reddy representing the management team. Investors can join via universal dial-in numbers (+91 22 6280 1146 / +91 22 7115 8047) or international toll-free numbers for the US, UK, Singapore, Hong Kong, and Australia.
Balaji Amines Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 02 Nov 2026, 5:30 am
Balaji Amines Limited has informed NSE that meeting of the Board of Directors of the Company is Scheduled on 2nd November, 2026, inter alia, to Consider and Approve Un-Audited Standalone and Consolidated Financial Results of the Company for Quarter and Half Year Ended 30th September, 2026
Intimation · 02 Nov 2026, 5:30 am
Balaji Amines Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Balaji Amines Limited has informed ....
Intimation · 02 Nov 2026, 5:30 am
Balaji Amines Schedules Board Meeting to Approve Q2 and H1 Results Balaji Amines Limited has scheduled a meeting of its Board of Directors on 2nd Nov'26 to consider, approve, and take on record the un-audited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in the company's securities by designated persons and their immediate relatives will reopen 48 hours after the declaration of the financial results.
Disclosure under Regulation 30(2) read with Regulation 30(6) of, and sub-para 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 01 Oct 2026, 5:51 pm
SEBI Issues Warning Letter to Balaji Amines Over Disclosure Lapses Balaji Amines received a Warning-cum-Advisory letter dated 29th Sep'26 from SEBI for non-compliance with LODR Regulation 30 disclosure norms. SEBI highlighted the company’s failure to report a DGFT order dated 13th Aug'24 placing it on the Denied Entity List and an FDA Maharashtra warning letter dated 10th Jan'25 regarding sub-standard Propylene Glycol quality. SEBI advised the company to improve compliance or face enforcement action. The company stated that the advisory letter has no material impact on its financials or operations.
Disclosure Under Regulation 30(2) Read with Regulation 30(6) of and sub-para 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 01 Oct 2026, 5:45 pm
Balaji Amines Receives FDA Warning Letter Over Product End-Use; No Financial Impact The Food & Drug Administration, Pune, issued a Directions and Warning Letter dated 10th Jan'25 to Balaji Amines after a customer unauthorizedly resold its technical-grade Propylene Glycol for pharmaceutical use, violating the Drugs and Cosmetics Act, 1940. No penalties, prosecution, or adverse orders were levied against the company. Balaji Amines stated there is no material impact on financials or operations and has updated documentation practices by mandating end-use declarations. The disclosure follows a SEBI directive dated 29th Sep'26.
Disclosure Under Regulation 30(2) Read with Regulation 30(6) of, and sub-para 20 of Para A of Part A of Schedule III of The SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 01 Oct 2026, 5:39 pm
Balaji Amines Receives DGFT Order for Export Obligation Violation The Joint Director General of Foreign Trade (DGFT), Pune, placed Balaji Amines Limited's license (No. 3111001781) on the Denied Entity List via an order dated 13th Aug'24, citing a violation of export obligations. The company confirmed there is no material impact on its financials, operations, or other activities. The disclosure was submitted on 1st Oct'26 following a SEBI directive dated 29th Sep'26, after the company initially deemed the order non-reportable under SEBI listing regulations.
Intimation of Completion of Tenure of Mr. Rajendrakumar Mohanprasad Tapadiya, Independent Director of the Balaji Speciality Chemicals Limited, a Material Subsidiary of the Company.
Change in Management · 29 Sept 2026, 12:06 am
Balaji Amines Material Subsidiary Director Completes Tenure Balaji Amines Limited announced that Mr. Rajendrakumar Mohanprasad Tapadiya has concluded his directorship at Balaji Speciality Chemicals Limited, a material subsidiary of the company. His tenure as Independent Director officially ended at the close of business hours on 28th Sep'26 following the completion of his second term, in compliance with SEBI Listing Regulations.
Intimation of Commissioning of Commercial Production of Acetonitrile (ACN) Plant with Advanced Technology under Expansion and Modernisation Programme.
Others (Uncategorized) · 24 Sept 2026, 8:58 pm
Balaji Amines Commences Commercial Production at Enhanced Acetonitrile Plant Balaji Amines Limited commenced commercial production at its modernized Acetonitrile (ACN) Plant located at Unit-III, Chincholi MIDC, Solapur, Maharashtra, effective 24th Sep'26. Commissioned with advanced technology under the company's expansion and modernization programme, the facility's installed capacity has expanded to 1,440 tonnes per month (TPM). The specialty chemical product will cater to both domestic and international markets.
Intimation of Withdrawal of Credit Rating on Account of No Due Certificates from the Banks
Others (Uncategorized) · 16 Sept 2026, 12:03 am
Balaji Amines: India Ratings Withdraws Credit Rating on Bank Facilities Following No Dues Balaji Amines announced that India Ratings and Research (Ind-Ra) has withdrawn the credit ratings assigned to its INR 1,950 million bank loan facilities, effective 11th Sep'26. The withdrawal follows the receipt of No Due Certificates from the lending banks, comprising State Bank of India and HDFC Bank. The rated facilities previously included INR 970 million in fund-based working capital limits and INR 980 million in non-fund-based working capital limits across both lenders.
Intimation Under Regulation 30 (Listing Obligation and Disclosure Requirements) Regulations, 2015- Withdrawal of Credit Rating.
Others (Uncategorized) · 12 Sept 2026, 7:21 pm
Balaji Amines Credit Rating Withdrawn by India Ratings Following Zero Debt Exposure India Ratings and Research (Ind-Ra) has withdrawn its credit rating on Balaji Amines Limited's INR 1,950 million bank loan facilities. The withdrawal follows the receipt of 'No Dues Certificates' from all lending banks and a formal request from the company, confirming that Balaji Amines has no outstanding debt exposure to any bank. The bank loan facilities previously held an 'IND AA/Negative/IND A1+' rating as of 13th Jun'25, downgraded from 'IND AA/Stable/IND A1+' on 14th Mar'24.
Schedule of Analyst/Investor Meet
Intimation · 17 Aug 2026, 10:31 pm
Balaji Amines Schedules Analyst Plant Visit and Management Meet Balaji Amines (NSE: BALAMINES) will host a physical plant visit and management meeting for analysts and investors on 25th Aug'26. The event will take place at the company's Solapur, Maharashtra facility. Discussions will be restricted to publicly available information, with no disclosure of unpublished price-sensitive information (UPSI). The schedule is subject to change based on participant or company exigencies.
Schedule of Analysts/ Investors meet under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation · 13 Aug 2026, 6:25 pm
Balaji Amines to Hold Virtual Investor Meeting on 21st Aug'26 Balaji Amines Ltd (NSE: BALAMINES) has scheduled a virtual group meeting with analysts and investors on 21st Aug'26 at 4:00 P.M. IST. The event will be hosted by Phillip Capital (India) Private Limited. Discussions will be restricted to publicly available information, with no disclosure of unpublished price-sensitive information (UPSI). The meeting is subject to change based on exigencies.
Investor Presentation on Q1 FY27 Financial Results
Investor Presentation · 29 Jul 2026, 10:29 pm
Balaji Amines Posts Strong Q1 FY27 Results, Driven by Volume and Margin Expansion Balaji Amines reported robust consolidated Q1 FY27 results, with revenue growing 25.7% YoY to ₹461 Cr. EBITDA surged 91.5% YoY to ₹121 Cr, with margins expanding to 26% from 17% in Q1 FY26. PAT grew 110.2% YoY to ₹78 Cr. Growth was supported by improved demand and the commissioning of India's first 100,000 TPA Dimethyl Ether plant. Expansion projects for NMM and Acetonitrile are on track for FY27 commissioning, with the company guiding for 22-23% EBITDA margins in FY27.
Press Release in connection with Un- Audited Financial Results of the Company for the Quarter Ended 30th June, 2026
Press Release · 28 Jul 2026, 12:58 am
Balaji Amines Q1FY27: Strong YoY Profit Growth Despite Lower Volumes Balaji Amines reported a strong Q1FY27 consolidated net profit of ₹78 crore, up 111% YoY, despite a 22% YoY decline in sales volume to 21,587 MT. Revenue grew 26% YoY to ₹461 crore, while EBITDA surged 89% YoY to ₹121 crore. EBITDA margin expanded significantly to 26% from 17% in Q1FY26, driven by stable commodity prices and consistent demand. The successful commissioning of the 100,000 TPA DME plant and ongoing expansions in NMM, ACN, and other specialty chemicals underpin future growth prospects.
Board Meeting Outcome
Outcome · 27 Jul 2026, 11:54 pm
Balaji Amines Q1FY27: Strong YoY Growth in Revenue and Profitability Balaji Amines reported strong consolidated results for Q1FY27 ending 30-Jun-26. Revenue from operations grew 27.2% YoY to ₹45,592.56 lakhs, while Profit After Tax (PAT) surged 113.9% YoY to ₹7,811.77 lakhs. QoQ, revenue increased 15.5% and PAT rose 20.6%. The core Amines & Speciality Chemicals segment drove performance, with its profit before tax jumping 132.5% YoY to ₹10,409.38 lakhs. Consolidated EPS for the quarter was ₹23.13, up from ₹11.73 in the prior-year quarter and ₹19.99 in the preceding quarter.
Results for the Quarter Ended 30th June, 2026
Financial Result · 27 Jul 2026, 11:37 pm
Balaji Amines Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 45,593 (+27.2% YoY | +15.5% QoQ) ■ EBITDA: 11,587 (+111.9% YoY | +22.9% QoQ) ■ EBITDA Margin (%): 25.4 (+1015 bps YoY | +154 bps QoQ) ■ PAT: 7,494 (+97.2% YoY | +18.6% QoQ) ■ EPS (INR): 23.1 (+97.2% YoY | +15.7% QoQ) Balaji Amines Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) Segmental Performance Amines & Speciality Chemicals ■ Revenue: 45,289 (+26.7% YoY | +15.1% QoQ) ■ EBIT: 10,545 (+132.1% YoY | +22.9% QoQ) ■ EBIT Margin (%): 23.3 (+1057 bps YoY | +148 bps QoQ) Hotel Division ■ Revenue: 799 (-22.2% YoY | -4.6% QoQ) ■ EBIT: 160 (-59.0% YoY | -2.4% QoQ) ■ EBIT Margin (%): 20.0 (-1799 bps YoY | +45 bps QoQ)
Balaji Amines Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Balaji Amines Limited has informed ....
Intimation · 27 Jul 2026, 5:30 am
Balaji Amines to Announce Q1FY27 Results on 27th July 2026 Balaji Amines has scheduled a Board of Directors meeting for 27th Jul'26 to consider and approve its un-audited standalone and consolidated financial results for the quarter ended 30th Jun'26. The trading window for designated persons, which closed on 27th Jun'26, will re-open 48 hours after the results are declared.
Outcome of the 38th Annual General Meeting of the Company held on Friday 10th July, 2026 at 12:00 (Noon) Through Video Conferencing (VC) or Other Audio Visual Means (OAVM) along with Scrutinizer''s ....
Annual General Meeting · 14 Jul 2026, 4:07 am
Proceedings of the 38th Annual General Meeting of the Company.
Annual General Meeting · 10 Jul 2026, 10:42 pm